Anterior Cruciate Ligament InjuriesNCT04185532
Treatment of Acute ACL Injuries in Young Patients Using a Rebound ACL Brace
A study testing Rebound ACL brace and physioterapy and Physioterapy in people with Anterior Cruciate Ligament Injuries and Anterior Cruciate Ligament Rupture, run by Frida Hansson, MD at 1 site in Sweden.
Trial summary
This study evaluates the use of a brace in acute anterior cruciate ligament (ACL) injuries in children and adolescents. Half of the participants will receive a so called rebound ACL brace together with a standardized rehab program supervised by a physiotherapist, while the other half will receive only the standardized… Read more about this study
- Who is it for?
- Ages Up to 17 yearsHealthy volunteers can take part
- Conditions the study is for
- Anterior Cruciate Ligament Injuries, Anterior Cruciate Ligament Rupture, Anterior Cruciate Ligament Tear
- What is being tested?
- Rebound ACL brace and physioterapy and Physioterapy
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 44 participants
- Where
- 1 siteSweden
- Study dates
- 8 Jan 2020to 17 Dec 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Up to 17 years
- All sexes
- Healthy volunteers accepted
- Child
Who may be able to join
- No previous significant knee injury
- Trauma followed by hemarthrosis and clinical suspicion of an acute ACL injury
- Acute ACL rupture seen on MRI
Who cannot join
- Previous ipsilateral knee surgery
- Associated injuries which require early surgical intervention
Trial locations and contacts
1 site in 1 country.
About this study
This study evaluates the use of a brace in acute anterior cruciate ligament (ACL) injuries in children and adolescents. Half of the participants will receive a so called rebound ACL brace together with a standardized rehab program supervised by a physiotherapist, while the other half will receive only the standardized rehab program supervised by a physiotherapist
Read the detailed description
A well known treatment of posterior cruciate ligament injuries in the acute phase is a brace which pushes the tibia anteriorly, and the result of the treatment is often successful with healing of the ligament. Similarly, in anterior cruciate ligament injuries, it is suggested that a rebound ACL brace which pushes the tibia posteriorly can facilitate healing of the ACL. It does not have as successful treatment results as the PCL brace, but the type and location of the ACL injury has in previous studies not been well defined. We will, after having described the localisation and type of ACL injury treat the intervention group with the rebound ACL brace and a standardized rehab program and the control group with standardized rehab program alone.
The randomization is made blockwise of 4, to treatment A= Brace+physiotherapy or B=Physioterapy. The groups are stratified for gender and age (<=14 years and >14 years)
- Conditions
- Anterior Cruciate Ligament Injuries, Anterior Cruciate Ligament Rupture, Anterior Cruciate Ligament Tear
- Being tested
- Rebound ACL brace and physioterapy, Physioterapy
- Keywords
- ACL, children and adolescents, rebound ACL brace
- Medical subject headings
- Anterior Cruciate Ligament Injuries
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Rebound ACL brace and physioterapyOther
Usage of rebound ACL brace and physioterapy supervised by physioterapist
PhysioterapyOther
Physioterapy supervised by physioterapist
| Study group | Role | What they receive |
|---|---|---|
| Rebound ACL brace and physiotherapy | Experimental | The intervention will be the use of rebound ACL brace for 9 weeks, which initially is locked followed by a gradually increased range of motion. A standardized rehab protocol is applied. Receives: Other: Rebound ACL brace and physioterapy |
| Physiotherapy | Active comparator | A standardized rehab protocol comparable to the experimental group but with no brace Receives: Other: Physioterapy |
What is being measured
The primary outcome is the main question the study is designed to answer.
Objective knee function
laxity measurement (KT-1000)
Measured: 6 months
Objective knee function
laxity measurement (KT-1000)
Measured: 12 months
Objective knee function
laxity measurement (KT-1000)
Measured: 24 months
objective knee function
muscle strength (measured by Biodex)
Measured: 6 months
objective knee function
muscle strength (measured by Biodex)
Measured: 12 months
objective knee function
muscle strength (measured by Biodex)
Measured: 24 months
objective knee function
jump tests
Measured: 6 months
objective knee function
jump tests
Measured: 12 months
objective knee function
jump tests
Measured: 24 months
Secondary outcomes (3)
Subjective knee function
EQ-5D-Y
Measured: 6, 12 and 24 months
Subjective knee function
The Knee injury and Osteoarthritis Outcome Score for children, KOOS child. 5 subscales, where each subscale's points are calculated to a scale from 0-100; zero representing extreme knee problems and 100 representing no knee problems
Measured: 6, 12 and 24 months
Activity level
Presented as Tegner activity scale. The Tegner activity scale is a one-item score that graded activity based on work and sports activities on a scale of 0 to 10. Zero represents disability because of knee problems and 10 represents national or international level soccer.
Measured: 6, 12 and 24 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted4 Dec 2019
- Study start8 Jan 2020
- Primary completion17 Dec 2024
- Study completion17 Dec 2024
Why it stopped: The study was stopped due to problems with the brace in the majority of the patients in the treatment group; such as skin lesions, non-fitting brace and severe itching. Furthermore, half of the patients went on to ACLR.
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Anterior Cruciate Ligament InjuriesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 44 participants (actual)
Sponsor and investigators
- Lead sponsor
- Frida Hansson, MD
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Frida Hansson, MD, Karolinska Institutet
- Investigators
- Frida Hansson, MD, PhD stud, Principal investigator, Karolinska Institutet
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04185532
- Sponsor's protocol ID
- 2018/1450-31
- Status last verified
- Dec 2024
- First submitted
- 25 Nov 2019
- Last updated
- 20 Dec 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices).
Publications
Jacobi M, Reischl N, Ronn K, Magnusson RA, Gautier E, Jakob RP. Healing of the Acutely Injured Anterior Cruciate Ligament: Functional Treatment with the ACL-Jack, a Dynamic Posterior Drawer Brace. Adv Orthop. 2016;2016:1609067. doi: 10.1155/2016/1609067. Epub 2016 Dec 7.
PubMed 28053787
Study at a glance
From the registry record, last updated by the sponsor on 20 Dec 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Treatment of Acute ACL Injuries in Young Patients Using a Rebound ACL Brace
- ClinicalTrials.gov ID
- NCT04185532
- Acronym / sponsor ID
- 2018/1450-31
- Conditions
- Anterior Cruciate Ligament Injuries, Anterior Cruciate Ligament Rupture, Anterior Cruciate Ligament Tear
- Keywords
- ACL, children and adolescents, rebound ACL brace
- Study type
- Interventional
- Recruitment status
- TerminatedReason stopped: The study was stopped due to problems with the brace in the majority of the patients in the treatment group; such as skin lesions, non-fitting brace and severe itching. Furthermore, half of the patients went on to ACLR.
- Enrolment
- 44 participants (actual)
- Lead sponsor
- Frida Hansson, MDUniversity, hospital or other
- Study start
- 8 Jan 2020 (actual)
- Primary completion
- 17 Dec 2024 (actual)
- Study completion
- 17 Dec 2024 (actual)
- First posted
- 4 Dec 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study evaluates the use of a brace in acute anterior cruciate ligament (ACL) injuries in children and adolescents. Half of the participants will receive a so called rebound ACL brace together with a standardized rehab program supervised by a physiotherapist, while the other half will receive only the standardized rehab program supervised by a physiotherapist
Detailed description
A well known treatment of posterior cruciate ligament injuries in the acute phase is a brace which pushes the tibia anteriorly, and the result of the treatment is often successful with healing of the ligament. Similarly, in anterior cruciate ligament injuries, it is suggested that a rebound ACL brace which pushes the tibia posteriorly can facilitate healing of the ACL. It does not have as successful treatment results as the PCL brace, but the type and location of the ACL injury has in previous studies not been well defined. We will, after having described the localisation and type of ACL injury treat the intervention group with the rebound ACL brace and a standardized rehab program and the control group with standardized rehab program alone.
The randomization is made blockwise of 4, to treatment A= Brace+physiotherapy or B=Physioterapy. The groups are stratified for gender and age (<=14 years and >14 years)
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Rebound ACL brace and physiotherapy | Experimental | Other: Rebound ACL brace and physioterapyThe intervention will be the use of rebound ACL brace for 9 weeks, which initially is locked followed by a gradually increased range of motion. A standardized rehab protocol is applied. |
| Physiotherapy | Active comparator | Other: PhysioterapyA standardized rehab protocol comparable to the experimental group but with no brace |
Who may qualify
- Ages
- Up to 17 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child
Key inclusion criteria (3 listed)
- No previous significant knee injury
- Trauma followed by hemarthrosis and clinical suspicion of an acute ACL injury
- Acute ACL rupture seen on MRI
Key exclusion criteria (2 listed)
- Previous ipsilateral knee surgery
- Associated injuries which require early surgical intervention
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Rebound ACL brace and physioterapyUsage of rebound ACL brace and physioterapy supervised by physioterapist | Other | Rebound ACL brace and physiotherapy |
| PhysioterapyPhysioterapy supervised by physioterapist | Other | Physiotherapy |
Primary outcome
Objective knee function
Time frame: 6 months
laxity measurement (KT-1000)
Objective knee function
Time frame: 12 months
laxity measurement (KT-1000)
Objective knee function
Time frame: 24 months
laxity measurement (KT-1000)
objective knee function
Time frame: 6 months
muscle strength (measured by Biodex)
objective knee function
Time frame: 12 months
muscle strength (measured by Biodex)
objective knee function
Time frame: 24 months
muscle strength (measured by Biodex)
objective knee function
Time frame: 6 months
jump tests
objective knee function
Time frame: 12 months
jump tests
objective knee function
Time frame: 24 months
jump tests
3 secondary outcomes
Subjective knee function
Time frame: 6, 12 and 24 months
Subjective knee function
Time frame: 6, 12 and 24 months
Activity level
Time frame: 6, 12 and 24 months
Results and safety
The study was stopped early (reason given: The study was stopped due to problems with the brace in the majority of the patients in the treatment group; such as skin lesions, non-fitting brace and severe itching. Furthermore, half of the patients went on to ACLR.). Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 Dec 2024.
- Background: PubMed 28053787Jacobi M, Reischl N, Ronn K, Magnusson RA, Gautier E, Jakob RP. Healing of the Acutely Injured Anterior Cruciate Ligament: Functional Treatment with the ACL-Jack, a Dynamic Posterior Drawer Brace. Adv Orthop. 2016;2016:1609067. doi: 10.1155/2016/1609067. Epub 2016 Dec 7.
- Individual participant dataSharing planned: Yes. Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices).
Related trials for Anterior Cruciate Ligament Injuries
Not yet recruiting
Stair Biomechanics and Vibration Study After ACLR
Anterior Cruciate Ligament Reconstruction (ACLR), Anterior Cruciate Ligament Injury
Not yet recruiting
Supporting Athletes' Return to Sports After ACL Reconstruction: A Study of a Psychological Readiness Program
Anterior Cruciate Ligament Reconstruction, Anterior Cruciate Ligament Injuries
Recruiting
Graded Exposure and Mindfulness Meditation for Patients Post-ACL Reconstruction
Anterior Cruciate Ligament Injuries
Not yet recruiting
Clinical and Biological Outcomes of BioBrace-Augmented ACL Reconstruction
Anterior Cruciate Ligament Injuries, Anterior Cruciate Ligament Rupture
Not yet recruiting
Effect of Transcutaneous Auricular Vagus Nerve Stimulation on Postoperative Recovery Quality in Patients Undergoing Anterior Cruciate Ligament Reconstruction
Anterior Cruciate Ligament Injuries, Recovery Quality
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Frida Hansson, MD, PhD stud principal investigator
Karolinska Institutet
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Rebound ACL brace and physioterapy and Physioterapy in people with Anterior Cruciate Ligament Injuries and Anterior Cruciate Ligament Rupture, run by Frida Hansson, MD at 1 site in Sweden.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: stopped early, as of the sponsor's last update on 20 Dec 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was stopped early (reason given: The study was stopped due to problems with the brace in the majority of the patients in the treatment group; such as skin lesions, non-fitting brace and severe itching. Furthermore, half of the patients went on to ACLR.). Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Objective knee function (time frame: 6 months). The study lists 9 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04185532, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Dec 2024.